Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Cancer treatments Stories

2013-02-19 08:31:34

SAN DIEGO, Feb. 19, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Vice President and Controller, Veronica Vallejo has been promoted to Chief Financial Officer effective February 8, 2013. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) "Veronica has been an integral part of our team since the inception of OncoSec and this...

2013-02-14 12:25:03

WASHINGTON, Feb. 14, 2013 /PRNewswire-USNewswire/ -- While advancements in cancer treatment over the last several decades have improved patient survival rates for certain cancers, some patients remain at risk of developing treatment-related leukemia, according to results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH). Chemotherapy is often a highly effective treatment for cancer, but certain drugs have also been shown in a range of...

Emerging Cancer Drugs May Cause Bone Tumors To Spread
2013-02-13 16:49:20

Washington University in St. Louis Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis. The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive. Working in mice, the investigators found that targeting the same protein that makes...

2013-02-11 23:04:40

Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that shows how insomnia can influence the occurrence of cancer. Toronto, ON (PRWEB) February 11, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that shows how insomnia can influence the occurrence of cancer. As Bel Marra Health reports in its article...

2013-02-11 08:25:08

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that their February 7th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com> red "register/ watch event now" button Aethlon Medical's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks. About Aethlon Medical Aethlon Medical...

2013-02-08 23:03:11

The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains. There is now an emerging world class sprinter in the race to create the “Super Drug” - Kalos Therapeutics San Diego, CA (PRWEB) February 08, 2013 The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that...

2013-02-06 08:26:03

SAN DIEGO, Feb. 6, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the 15(th) Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City, on Tuesday, February 12th at 3:00PM Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO) ABOUT THE BIO CEO...

2013-02-04 08:25:21

PRINCETON, N.J., Feb. 4, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development-stage biopharmaceutical company, announced today the formation of a Medical Advisory Board (MAB) to provide medical/clinical strategic guidance to the Company as it advances the development of SGX942 for the treatment of oral mucositis, a common complication of cancer treatments. Comprised of cancer supportive care thought leaders with extensive experience in oral mucositis,...

2013-02-01 08:25:33

BETHESDA, Md., Feb. 1, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTCPINK: TNIB) has signed an exclusive licensing agreement for all of the intellectual property developed at Pennsylvania State by Dr. Ian S. Zagon, Dr. Patricia J. McLaughlin and Dr. Jill P. Smith for the treatment of cancer. The patents cover methods and formulations related to the treatment and prevention of cancers, particularly gastrointestinal cancer. More specifically, the present inventions describe the use of drugs that...

2013-01-29 23:03:21

One of the California's most modern Cancer Centers, El Portal Comprehensive Cancer is moving to a much-anticipated new location in Merced. Their new office features a plethora of innovative, highly-effective treatments including stereotactic radiotherapy and high dose rate brachytherapy. Merced, California (PRWEB) January 29, 2013 El Portal Comprehensive Cancer is moving to a much-anticipated new location in Merced that will better enable them to help members of the community who are...